The ALDH5A1 gene gives your body instructions for an enzyme that helps break down byproducts of GABA, a brain chemical involved in calming nerve signals. This gene helps your body keep certain brain chemicals in balance. When the gene does not work properly, these substances can build up and cause succinic semialdehyde dehydrogenase deficiency, a rare inherited condition. People with this condition may have developmental delay, low muscle tone, speech difficulties, seizures, or sleep and behavior changes.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ALDH5A1Gene function
What if the gene works
The ALDH5A1 gene helps clear a breakdown product of GABA, a brain signaling chemical. This supports normal energy production and keeps related substances from building up in cells.
Risk
What if the gene does not work
When the ALDH5A1 gene does not work properly, people can develop succinic semialdehyde dehydrogenase deficiency, which often affects development, speech, movement, and seizures. Milder to more severe variants can influence when features appear and how strongly they affect daily life.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently established specifically for pathogenic variants in the ALDH5A1 gene; care is supportive and guided by symptoms rather than by the exact variant. The ALDH5A1 gene is being studied as a target for gene therapy and other approaches that aim to lower harmful metabolite buildup.
Conditions associated with ALDH5A1
Gene function
What if the gene works
In the brain and other tissues, cells use the ALDH5A1 gene to finish an important step in GABA processing. Your cells rely on the ALDH5A1 gene to turn a temporary GABA breakdown product into a form they can reuse in normal metabolism. This is a key part of what the ALDH5A1 gene does in the body.
The ALDH5A1 gene helps convert succinic semialdehyde, a short lived byproduct of GABA breakdown, into succinate. This completes an important step in the normal turnover of GABA, a calming chemical messenger.
The succinate made through this step can enter the citric acid cycle, a main pathway cells use to release energy from food. This connects GABA processing with everyday energy needs inside the cell.
By clearing a temporary GABA byproduct, the ALDH5A1 gene supports smooth chemical signaling in the brain and nervous system. It helps nerve cells finish one message cycle before moving on to the next.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALDH5A1 gene can make the protein unstable, less active, or too short to work, so cells may not break down certain brain chemicals normally. How ALDH5A1 gene variants affect enzyme function depends on the change: some leave a little activity, while more severe variants can almost eliminate it. Variants that disrupt the active site or folding usually have the largest impact and often link to earlier or more marked symptoms.
How variants are linked to conditions
Certain variants in the ALDH5A1 gene cause succinic semialdehyde dehydrogenase deficiency, often called SSADH deficiency. This ALDH5A1 gene variant condition is a rare inherited condition linked to developmental delay, low muscle tone, speech and learning difficulties, seizures, and sleep or behavior changes. Signs can differ a lot from one person to another, so some people are identified early in childhood while others are diagnosed later.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALDH5A1, risk is mostly set by inheritance: a child usually develops the condition only after receiving two changed copies, one from each parent. Family history and whether both biological parents carry an ALDH5A1 variant are the main factors that change risk. There is not enough evidence to say lifestyle changes lower this genetic risk.
Inheritance of ALDH5A1 variants
Variants in the ALDH5A1 gene are inherited in an autosomal recessive pattern. In practical terms, how ALDH5A1 variants are inherited usually means a child receives one altered copy from each parent, and the parents are often healthy carriers. When both parents carry an ALDH5A1 gene variant, each pregnancy has a 25% chance of producing a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child who inherited neither variant. This pattern affects males and females equally.
What does my ALDH5A1 result mean for my family?
For families with an ALDH5A1-related condition, close relatives may want to learn whether they also carry the same gene change, especially brothers, sisters, and relatives planning children. Parents of an affected child are usually healthy carriers, and siblings may also be carriers or, less often, have the condition. Family members’ results can help clarify chances for future children and whether others in the family could be affected.
Genetic information
Genetic testing
How you find out about variants
In practice, ALDH5A1 genetic testing usually uses a blood sample or cheek swab to read the DNA sequence of the ALDH5A1 gene. It can show whether a person has pathogenic variants in both copies of the gene or carries one variant.
When should I consider getting a genetic test?
Consider ALDH5A1 testing if a child or adult has signs of a rare inherited condition that can affect development, speech, movement, or cause seizures, especially when a related body chemical is high on lab tests. It can also be useful when this condition is already known in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although what it can tell you varies depending on the condition and the type of variant involved. Over time, many other factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a medicine more slowly or more quickly, which can change how much of the drug reaches the body and how long it stays active. This can influence how well a treatment works or how likely side effects are, and it is one reason medication response often varies even when people take the same dose.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how the body processes a drug and how strong its effects are. This information can support more informed and individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the ALDH5A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general medication questions or new symptoms are best discussed with your doctor.
History
Early reports of children with an unusual pattern of developmental symptoms and a distinctive lab finding led doctors to recognize what is now called SSADH deficiency, a condition linked to the ALDH5A1 gene. Initially understood only through visible traits, later recognized as tied to a specific gene, this work took shape in the 1980s as improved testing made the condition easier to identify. In the years that followed, researchers mapped the responsible gene to chromosome 6 and confirmed that variants in the ALDH5A1 gene were the cause in affected families. From these first observations, research expanded steadily. That progress helped connect clinical care, brain imaging, and genetic testing, giving families a clearer explanation for a condition that had once been hard to name.